Influence of microglial activation on neuronal function in Alzheimer's and Parkinson's disease dementia

Alzheimer's disease (AD) and Parkinson's disease (PD) are the two common neurodegenerative diseases characterized by progressive neuronal dysfunction in the presence of pathological microglial activation.

[1]  György Buzsáki,et al.  Predominant Enhancement of Glucose Uptake in Astrocytes versus Neurons during Activation of the Somatosensory Cortex , 2010, The Journal of Neuroscience.

[2]  Pierre J Magistretti,et al.  Brain energy metabolism: focus on astrocyte-neuron metabolic cooperation. , 2011, Cell metabolism.

[3]  W. Streit,et al.  Microglia and Alzheimer's disease pathogenesis , 2004, Journal of neuroscience research.

[4]  H. Berendse,et al.  Emerging roles of microglial activation and non-motor symptoms in Parkinson's disease , 2012, Progress in Neurobiology.

[5]  C. DeCarli,et al.  What does fluorodeoxyglucose PET imaging add to a clinical diagnosis of dementia? , 2007, Neurology.

[6]  Z Walker,et al.  Microglial activation and amyloid deposition in mild cognitive impairment , 2009, Neurology.

[7]  Masamichi Yokokura,et al.  Neuroinflammation in the living brain of Parkinson's disease. , 2009, Parkinsonism & related disorders.

[8]  Nick C Fox,et al.  Amyloid, hypometabolism, and cognition in Alzheimer disease , 2007, Neurology.

[9]  F. Heppner,et al.  Microglia actions in Alzheimer’s disease , 2013, Acta Neuropathologica.

[10]  M. Glymour,et al.  Relationship between baseline brain metabolism measured using [18F]FDG PET and memory and executive function in prodromal and early Alzheimer’s disease , 2012, Brain Imaging and Behavior.

[11]  Gernot Riedel,et al.  Synthetic and plant‐derived cannabinoid receptor antagonists show hypophagic properties in fasted and non‐fasted mice , 2009, British journal of pharmacology.

[12]  Mitsuru Kikuchi,et al.  In vivo changes in microglial activation and amyloid deposits in brain regions with hypometabolism in Alzheimer’s disease , 2011, European Journal of Nuclear Medicine and Molecular Imaging.

[13]  H. Kettenmann,et al.  Toll‐like receptor activation reveals developmental reorganization and unmasks responder subsets of microglia , 2012, Glia.

[14]  P. Mcgeer,et al.  Local neuroinflammation and the progression of Alzheimer’s disease , 2011, Journal of NeuroVirology.

[15]  Midori A. Yenari,et al.  Microglial activation in stroke: Therapeutic targets , 2010, Neurotherapeutics.

[16]  Paul A. Bottomley,et al.  19F magnetic resonance imaging , 1977 .

[17]  T. Jones,et al.  Spectral Analysis of Dynamic PET Studies , 1993, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[18]  V. Perry,et al.  Microglia in neurodegenerative disease , 2010, Nature Reviews Neurology.

[19]  Karl J. Friston,et al.  Statistical parametric mapping , 2013 .

[20]  Jean-Claude Baron,et al.  Resting-state brain glucose utilization as measured by PET is directly related to regional synaptophysin levels: a study in baboons , 2003, NeuroImage.

[21]  Jau-Shyong Hong,et al.  Why neurodegenerative diseases are progressive: uncontrolled inflammation drives disease progression. , 2008, Trends in immunology.

[22]  R. Mrak,et al.  Microglia and neuroinflammation: a pathological perspective , 2004 .

[23]  Nick C Fox,et al.  Conversion of amyloid positive and negative MCI to AD over 3 years , 2009, Neurology.

[24]  Chunfu Wu,et al.  Activated microglia are implicated in cognitive deficits, neuronal death, and successful recovery following intermittent ethanol exposure , 2013, Behavioural Brain Research.

[25]  R. Edelman,et al.  Magnetic resonance imaging (2) , 1993, The New England journal of medicine.

[26]  C. Jack,et al.  Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade , 2010, The Lancet Neurology.

[27]  C. Rowe,et al.  Amyloid load in Parkinson’s disease dementia and Lewy body dementia measured with [11C]PIB positron emission tomography , 2008, Journal of Neurology, Neurosurgery, and Psychiatry.

[28]  Philippe Hantraye,et al.  Reactive Astrocytes Overexpress TSPO and Are Detected by TSPO Positron Emission Tomography Imaging , 2012, The Journal of Neuroscience.

[29]  M. Tansey,et al.  Molecular Neurodegeneration BioMed Central Review , 2009 .

[30]  J. Morris,et al.  Current concepts in mild cognitive impairment. , 2001, Archives of neurology.

[31]  F. Turkheimer,et al.  Reference and target region modeling of [11C]-(R)-PK11195 brain studies. , 2007, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[32]  P. Mcgeer,et al.  Reactive microglia are positive for HLA‐DR in the substantia nigra of Parkinson's and Alzheimer's disease brains , 1988, Neurology.

[33]  B. Stoica,et al.  Traumatic brain injury in aged animals increases lesion size and chronically alters microglial/macrophage classical and alternative activation states , 2013, Neurobiology of Aging.

[34]  J. Cummings,et al.  Intellectual Impairment in Parkinson's Disease: Clinical, Pathologic, and Biochemical Correlates , 1988, Journal of geriatric psychiatry and neurology.

[35]  V J Cunningham,et al.  Cortical dysfunction in non-demented Parkinson's disease patients: a combined (31)P-MRS and (18)FDG-PET study. , 2000, Brain : a journal of neurology.

[36]  Paul Edison,et al.  Microglia, Amyloid, and Glucose Metabolism in Parkinson’s Disease with and without Dementia , 2013, Neuropsychopharmacology.

[37]  R. Veerhuis,et al.  Biomarkers of inflammation and amyloid-β phagocytosis in patients at risk of Alzheimer disease , 2010, Experimental Gerontology.

[38]  D. Baker,et al.  Inflammation in neurodegenerative diseases , 2010, Immunology.

[39]  Pierre J Magistretti,et al.  Amyloid-β Aggregates Cause Alterations of Astrocytic Metabolic Phenotype: Impact on Neuronal Viability , 2010, The Journal of Neuroscience.

[40]  Alexander Hammers,et al.  A systematic comparison of kinetic modelling methods generating parametric maps for [11C]-(R)-PK11195 , 2007, NeuroImage.

[41]  Martin Rossor,et al.  Microglia, amyloid, and cognition in Alzheimer's disease: An [11C](R)PK11195-PET and [11C]PIB-PET study , 2008, Neurobiology of Disease.

[42]  J. Trojanowski,et al.  Parkinson's disease dementia: convergence of α-synuclein, tau and amyloid-β pathologies , 2013, Nature Reviews Neuroscience.

[43]  P. Stroman,et al.  The role(s) of astrocytes and astrocyte activity in neurometabolism, neurovascular coupling, and the production of functional neuroimaging signals , 2011, The European journal of neuroscience.

[44]  C. Holmes.  Review: Systemic inflammation and Alzheimer's disease , 2013, Neuropathology and applied neurobiology.

[45]  H. Ross,et al.  A 10-year study of the incidence of and factors predicting dementia in Parkinson’s disease , 2000, Neurology.